Trastuzumab derived HER2-specific CARs for the treatment of trastuzumab-resistant breast cancer: CAR T cells penetrate and eradicate tumors that are not accessible to antibodies

Trastuzumab derived HER2-specific CARs for the treatment of trastuzumab-resistant breast cancer: CAR T cells penetrate and eradicate tumors that are not accessible to antibodies:



Publication date: Available online 11 April 2020

Source: Cancer Letters

Author(s): Arpad Szoor, Gabor Toth, Barbara Zsebik, Viktoria Szabo, Zelig Eshhar, Hinrich Abken, Gyorgy Vereb